市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| CAGR: | 5.5 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
预计加拿大微创手术器械市场在预测期内的复合年增长率为 5.5%。加拿大微创手术器械市场增长的主要因素包括生活方式相关和慢性疾病的患病率增加，以及该国老年人口的增加和技术进步。
随着加拿大老年人口的增加，慢性病负担的增加可能会导致对微创手术设备的需求增加。例如，根据心脏和中风基金会 2019 年的报告，加拿大每年有超过 62,000 人中风，而且这个数字预计还会上升。该国超过 405,000 人受到中风的影响。此外，心脏瓣膜病和心力衰竭患者在 90 天内死于医院的人数是心脏瓣膜病患者的 7.6 倍。
根据加拿大慢性疼痛协会 (CPAC) 2019 年调查报告，估计慢性疼痛患者的生活质量正在下降，疼痛加剧。此外，17-31% 的人报告有慢性疼痛。50% 的住院患者报告有中度至重度强度的急性疼痛。据估计，慢性疼痛管理的年度直接医疗费用为每位患者 10,000-14,000 美元。因此，预计慢性病的增加将在不久的将来增加对微创手术设备的需求并推动市场增长。
Scope of the report
As per the scope of this report, minimally-invasive surgical devices refer to electrosurgical systems, robot-assisted surgical systems, and surgical equipment, which are used during the minimally-invasive procedure. The Canada Minimally Invasive Surgery Devices Market is segmented by product and application.
主要市场趋势
正在申请中的胃肠道部分预计将成为预测期内增长最快的部分。
推动胃肠道增长的主要因素是年轻人、成人和老年人胃肠道疾病发病率的上升。消化不良、肠易激综合征和便秘是胃肠道疾病的一些例子。微创手术在良性疾病中得到普及，并证明了其优于传统方法的安全性和有效性，因此在过去几年中受到了广泛关注。
加拿大是世界上炎症性肠病（IBD）发病率和患病率最高的国家。例如，根据 Gilaad G Kaplan 等人在 2019 年加拿大胃肠病学协会杂志上发表的一篇研究文章，2018 年，加拿大约有 270,000 人患有炎症性肠病 (IBD)，预计这一数字将上升至2030 年将有 403,000 名加拿大人。在 Canda，炎症性肠病影响所有年龄组，其中青少年和年轻人的诊断风险最高。因此，由于上述因素，预计在预测期内将出现显着增长。
To understand key trends, Download Sample Report
竞争格局
由于市场上有一些关键参与者，加拿大微创手术器械市场得到巩固。一些市场参与者包括奥林巴斯公司、CONMED 公司、美敦力公司、布劳恩梅尔松根公司（Aesculap 公司）、史赛克公司、雅培实验室、强生公司、施乐辉公司、齐默生物美特等。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Assumptions
-
1.2 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Prevalence of Lifestyle-related and Chronic Disorders
-
4.2.2 Technological Advancements
-
-
4.3 Market Restraints
-
4.3.1 Shortage of Experienced Professionals
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Products
-
5.1.1 Handheld Instruments
-
5.1.2 Guiding Devices
-
5.1.3 Electrosurgical Devices
-
5.1.4 Endoscopic Devices
-
5.1.5 Laproscopic Devices
-
5.1.6 Monitoring and Visualization Devices
-
5.1.7 Robotic Assisted Surgical Systems
-
5.1.8 Ablation Devices
-
5.1.9 Laser Based Devices
-
5.1.10 Other MIS Devices
-
-
5.2 By Application
-
5.2.1 Aesthetic
-
5.2.2 Cardiovascular
-
5.2.3 Gastrointestinal
-
5.2.4 Gynecological
-
5.2.5 Orthopedic
-
5.2.6 Urological
-
5.2.7 Other Applications
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Olympus Corporation
-
6.1.2 Medtronic PLC
-
6.1.3 Abbott Laboratories Inc
-
6.1.4 CONMED Corporation
-
6.1.5 Braun Melsungen AG (Aesculap Inc)
-
6.1.6 Johnson & Johnson
-
6.1.7 Smith & Nephew Plc
-
6.1.8 Stryker Corporation
-
6.1.9 Zimmer Biomet Holdings Inc
-
6.1.10 Koninklijke Philips N.V.
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Canada Minimally Invasive Surgery Devices Market market is studied from 2018 - 2026.
What is the growth rate of Canada Minimally Invasive Surgery Devices Market?
The Canada Minimally Invasive Surgery Devices Market is growing at a CAGR of 5.5% over the next 5 years.
Who are the key players in Canada Minimally Invasive Surgery Devices Market?
Olympus Corporation, Medtronic PLC, Abbott Laboratories, CONMED Corporation, Braun Melsungen AG (Aesculap Inc) are the major companies operating in Canada Minimally Invasive Surgery Devices Market.
